ImmuneBiotech
PrivateLast Round
Growth Equity
May 4, 2026
Total Funding Raised
$165M
Momentum Score
25 /100
Company Overview
ImmuneBiotech is a biotechnology company that develops, markets, and commercializes therapeutically effective probiotic products designed with pharmaceutical precision to manage gastrointestinal and neurological conditions.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneBiotech Comps
Public and private peers based on sector, stage, and business model.
ImmuneBiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 4, 2026 |
ImmuneBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Growth Equity |
| RA Capital Management | Growth Equity |
| Omega Funds | Growth Equity |
| OrbiMed | Growth Equity |
| Novo Holdings | Growth Equity |
| Sanofi Ventures | Growth Equity |
| Pivotal bioVenture Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$165M round led by OrbiMed.
- Jan 2, 2026
Monthly visitors grew 206% MoM, from 53 to 162.
ImmuneBiotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuneBiotech's valuation, stock price, and market status.
